Search

everythinglearnresearchcommunity

for

Search:↓

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

A machine learning model can predict alopecia areata early using specific gene markers.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Improving oral health may help hair regrowth in children with alopecia areata.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Microbes might play a role in vitiligo.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.